Explore detailed information on the case number App_44530/2024 involving Amgen Ab, Amgen S.R.L., Amgen Gmbh, and others and which was filed on 31 Jul, 2024.

Case Details

    Case Number:

    App_44530/2024

    Filing Date:

    31 Jul, 2024

    Proceeding Type:

    Application

    Action/Application:

    Generic Application

    Plaintiffs:

    • Amgen Ab Represented By Tilman Muller-Stoy
    • Amgen S.R.L. Represented By Tilman Muller-Stoy
    • Amgen Gmbh Represented By Tilman Muller-Stoy
    • Amgen Technology (Ireland) Unlimited Company Represented By Tilman Muller-Stoy
    • Amgen Biofarmaceutica Lda. Represented By Tilman Muller-Stoy
    • Amgen S.A.S. Represented By Tilman Muller-Stoy
    • Amgen Zdravila D.O.O. Represented By Tilman Muller-Stoy
    • Amgen N.V. Represented By Tilman Muller-Stoy

Case Decision

    Decision Date:

    Aug 8, 2024

    Decision Document:

More cases on Amgen Ab

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
App_33361/2025Jul 22, 2025Amgen Technology Ireland Unlimited, Amgen AB, Amgen, Amgen Zdravila DOO, Amgen Biofarmaceutica LDA, Amgen, Amgen, Amgen -
App_33372/2025Jul 21, 2025Amgen Zdravila DOO, Amgen, Amgen AB, Amgen Technology Ireland Unlimited, Amgen, Amgen Biofarmaceutica LDA, Amgen, AmgenAlexion Pharmaceuticals
App_32867/2025Jul 15, 2025Amgen, Amgen Biofarmaceutica LDA, Amgen, Amgen, Amgen Technology Ireland Unlimited, Amgen AB, Amgen Zdravila DOO, Amgen -